Global Continuous Renal Replacement Therapy Devices Market Report and Forecast 2025-2034

Global Continuous Renal Replacement Therapy Devices Market Outlook

The continuous renal replacement therapy devices market attained a value of USD 1.4 billion in 2024, driven by the rising demand for dialysis. The market is anticipated to grow at a CAGR of 8.18% during the forecast period of 2025-2034 to attain a value of USD 2.8 billion by 2034.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Key Company News

In February 2021, DaVita achieved a record by adding the secure DaVita Care Connect telemedicine platform to its home dialysis curriculum. As one of many connected technologies, it aims to improve the care experience and outcomes for people who choose home care. Such developments are likely to add significantly to the growth of the global continuous renal replacement therapy devices market.

In December 2020, an emergency cardiac renal paediatric dialysis device was launched by Medtronic plc. Haemodialysis is recommended for patients with acute kidney injury or fluid overload. Patients weighing between 2.5 and 10 kilograms can receive continuous renal replacement therapy devices (CRRT).

In April 2020, during the pandemic, Fresenius Medical Care, a global provider of dialysis facilities and products, issued a notice advocating clinical care for patients with advanced chronic kidney disease. Patients requiring renal replacement therapy during the COVID-19 crisis should receive treatment as determined by their doctor.

In April 2020, it was announced that Baxter International is expanding its worldwide offering of dialysis products. Because of the increase in COVID-19 patients requiring ongoing renal replacement therapy (CRRT), the company experienced extreme demand for multiple acute dialysis products. In order to address these challenges, the company has been working with governments around the world.

Introduction

An acute kidney injury patient with impaired haemodynamics often requires continuous renal replacement therapy devices (CRRT) a device, for support of the renal function.

The loss or damage of kidney function occurs suddenly within hours or days as a result of acute renal failure (ARF). As a result of kidney injury, waste products build up in the blood and the kidneys can't adequately balance body fluids.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Acute kidney injury can also affect organs, such as the lungs, brain and heart. It is common among patients in hospitals and ICUs, particularly in elders. If it is not treated, this condition can pose a serious risk of organ failure and death.

In addition, the global continuous renal replacement therapy devices market is expected to be driven by the growing cases of diabetes and hypertension as a result of acute kidney injury, the government's commitment to improving medical facilities, and an increase in dialysis facilities.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Market Scenario

The one key aspect that accelerate the development of the global kidney dialysis apparatus market is the increase in cases of chronic kidney disease (CKD) among the elderly. It is common for older people to develop kidney failure.

The elderly population is more prone to various diseases due to a weakened immune system and other complications. Diabetes is a common disease that causes many other health problems. Kidney failure is one of the most common health problems caused by diabetes. If it is improperly treated, diabetic patients can develop abnormal kidney function and, in some cases, even complete organ failure. An increased cases of diabetes may increase the risk of growing kidney disease.

The major drivers of the global continuous renal replacement therapy devices market include the rise in demand for procedures, approvals, and new launches of continuous renal replacement therapy devices. The growth of the market is aided by technical progressions in manufacturing.

Technological Advancements and Rising Demand for Homecare to be Among the Key Market Trends

Manufacturers are now developing precision instruments to ensure safe and reliable performance during kidney replacement therapy procedures. To facilitate operation, these devices are equipped with a modern and intuitive interface.

It is expected that kidney disease will increase the demand for dialysis equipment and encourage manufacturers to develop new products in order to meet this demand.

In addition, the growing demand for home care has prompted manufacturers to focus on developing new and innovative dialysis machines.

North America and Asia Pacific to Contribute Significantly to the Global Continuous Renal Replacement Therapy Devices Market

As the global market grows, North America is expected to take a significant share. There are several lifestyle-related diseases in the United States, such as diabetes, obesity, hypertension, and other diseases associated with a sedentary lifestyle. That is driving the regional market to grow.

Dialysis equipment market growth will be dominated by the Asia Pacific region. Emerging economies with dense populations will drive market growth in the region. It is because kidney diseases are becoming more prevalent in the region. As patients demand more advanced medical equipment, technological advancements are increasing. The continuous renal replacement therapy devices market is driven by these factors.

Therapeutic Landscape

A continuous renal replacement therapy devices is a type of blood purification therapy used in cases of acute kidney disease. The annual average cost of a continuous renal replacement therapy devices machine falls somewhere between USD 10000 to USD 30000. In order to perform continuous renal replacement therapy devices on a patient, these six medical products are required:

Blood Purifier: This device pumps blood, regulates blood flow, and contains software that monitors the safe delivery of therapy.

Dialysate: It is a liquid that removes toxins from the filter.

Fluid Replacement: A special sterile fluid that is used to flush toxins out of the body and replace electrolytes and other blood components.

Filter: Filter has the mechanical component that removes toxins from liquids and urine.

Anticoagulant: Blood clot prevention drug that facilitates blood flow through the system.

Blood Warmer: During blood purification treatment, a blood warmer keeps the patient's blood temperature at an appropriate level.

Clinical Trials

Emerging Device- In June 2021, A new version of Baxter's next-generation CRRT platform, PrisMax 2, has been released. As part of the TrueVue digital health portfolio, the system offers a new solution for the company. An ongoing continuous renal replacement therapy devices (CRRT) can be delivered more quickly using this technology.

Competitive Landscape

The report gives an in-depth analysis of the top competitors involved in the continuous renal replacement therapy devices market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:

• Medtronic

• Fresenius Medical care AG and Co. KGaA

• Anjue Medical Equipment Co. Ltd.

• B.Braun Melsungen AG

• Infomed SA

• Baxter International Inc.

• NxStage Medical, Inc.

• Medica S.p.A.

• SWS Hemodialysis Care Co., Ltd.

• Dialco Medical Inc.

• Asahi Kasei Corporation

• NIKKISO Co., ltd.

Key Highlights of the Report